Last reviewed · How we verify
somatropin AQ
At a glance
| Generic name | somatropin AQ |
|---|---|
| Also known as | Somatropin injection, rhGH |
| Sponsor | Changchun GeneScience Pharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Headache
- Vomiting
- Upper respiratory tract infection
- Injection site bruising
- Pharyngitis streptococcal
- Rash
- Pyrexia
- Nasopharyngitis
Key clinical trials
- Human Models of Selective Insulin Resistance: Pancreatic Clamp (PHASE1)
- Pancreatic Clamp in NAFLD (PHASE1)
- Growth Hormone Therapy for Wasting in Cystic Fibrosis (PHASE1)
- Dexamethasone/Pancreatic Clamp P&F (PHASE1)
- Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children (PHASE3)
- Growth Hormone Use in Adults With Prader-Willi Syndrome (PHASE3)
- Trial of Growth Hormone Therapy in Pediatric Crohn's Disease (PHASE2)
- Effect of Growth Hormone on Bone Metabolism in Anorexia Nervosa (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |